Oncology
RT inhibitors downregulate cell proliferation and restore thyrotropin signaling
Published in Cancer Weekly, December 13th, 2005
"Two classes of repeated genomic elements, retrotransposons and endogenous retroviruses, encode for endogenous nontelomeric reverse transcriptase (RT), a gene that is downregulated in differentiated cells but is highly expressed in embryonic and transformed tissues.
"Two non-nucleosidic RT inhibitors, efavirenz and nevirapine, currently used in HIV treatment, reversibly downregulate tumor growth and induce differentiation in several human tumor cell models," researchers in Italy report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-12-13)
More Articles from Cancer Weekly
- Cancer Risk Factors
Night work might be related to breast cancer risk - Cancer Therapy
Interferon treatment increases virotherapy for advanced hepatocellular carcinoma - Healthcare Costs
Taxane test-dose reduced cost associated with hypersensitivity reaction - Anemia
First long-term phase II study of CERA in renal patients shows control of anemia - Apoptosis
2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) induced apoptosis in pancreatic cancer - Apoptosis
Biological stimuli of neuroblastoma cell response analyzed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
